Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MPW vs GMRE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MPW
Medical Properties Trust, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$3.37B
5Y Perf.-68.8%
GMRE
Global Medical REIT Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$94M
5Y Perf.-35.4%

MPW vs GMRE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MPW logoMPW
GMRE logoGMRE
IndustryREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$3.37B$94M
Revenue (TTM)$972M$148M
Net Income (TTM)$-199M$2M
Gross Margin55.7%68.8%
Operating Margin38.1%24.9%
Forward P/E49.4x595.7x
Total Debt$128M$654M
Cash & Equiv.$541M$7M

MPW vs GMRELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MPW
GMRE
StockMay 20Mar 26Return
Medical Properties … (MPW)10031.3-68.8%
Global Medical REIT… (GMRE)10064.6-35.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: MPW vs GMRE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GMRE leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Medical Properties Trust, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
MPW
Medical Properties Trust, Inc.
The Real Estate Income Play

MPW is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.30
  • Lower volatility, beta 0.30, Low D/E 2.8%, current ratio 9.77x
  • Beta 0.30, current ratio 9.77x
Best for: income & stability and sleep-well-at-night
GMRE
Global Medical REIT Inc.
The Real Estate Income Play

GMRE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth -1.8%, EPS growth -94.6%, 3Y rev CAGR 6.1%
  • 308.1% 10Y total return vs MPW's -0.3%
  • -1.8% FFO/revenue growth vs MPW's -2.4%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGMRE logoGMRE-1.8% FFO/revenue growth vs MPW's -2.4%
ValueMPW logoMPWLower P/E (49.4x vs 595.7x)
Quality / MarginsGMRE logoGMRE1.7% margin vs MPW's -20.4%
Stability / SafetyMPW logoMPWBeta 0.30 vs GMRE's 0.48, lower leverage
DividendsGMRE logoGMRE63.5% yield; 5-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MPW logoMPW+18.6% vs GMRE's +0.1%
Efficiency (ROA)GMRE logoGMRE0.2% ROA vs MPW's -1.3%

MPW vs GMRE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGMRELAGGINGMPW

Income & Cash Flow (Last 12 Months)

Evenly matched — MPW and GMRE each lead in 3 of 6 comparable metrics.

MPW is the larger business by revenue, generating $972M annually — 6.6x GMRE's $148M. GMRE is the more profitable business, keeping 1.7% of every revenue dollar as net income compared to MPW's -20.4%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMPW logoMPWMedical Propertie…GMRE logoGMREGlobal Medical RE…
RevenueTrailing 12 months$972M$148M
EBITDAEarnings before interest/tax$663M$95M
Net IncomeAfter-tax profit-$199M$2M
Free Cash FlowCash after capex$0$19M
Gross MarginGross profit ÷ Revenue+55.7%+68.8%
Operating MarginEBIT ÷ Revenue+38.1%+24.9%
Net MarginNet income ÷ Revenue-20.4%+1.7%
FCF MarginFCF ÷ Revenue+23.7%+12.6%
Rev. Growth (YoY)Latest quarter vs prior year+14.9%+18.7%
EPS Growth (YoY)Latest quarter vs prior year+123.2%-166.2%
Evenly matched — MPW and GMRE each lead in 3 of 6 comparable metrics.

Valuation Metrics

GMRE leads this category, winning 3 of 5 comparable metrics.

On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than MPW's 105.4x.

MetricMPW logoMPWMedical Propertie…GMRE logoGMREGlobal Medical RE…
Market CapShares × price$3.4B$94M
Enterprise ValueMkt cap + debt − cash$3.0B$741M
Trailing P/EPrice ÷ TTM EPS-17.12x115.29x
Forward P/EPrice ÷ next-FY EPS est.49.43x595.67x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple105.41x8.35x
Price / SalesMarket cap ÷ Revenue3.47x0.68x
Price / BookPrice ÷ Book value/share0.74x0.17x
Price / FCFMarket cap ÷ FCF14.62x
GMRE leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

MPW leads this category, winning 4 of 6 comparable metrics.

GMRE delivers a 0.5% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-4 for MPW. MPW carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to GMRE's 1.18x. On the Piotroski fundamental quality scale (0–9), MPW scores 5/9 vs GMRE's 4/9, reflecting solid financial health.

MetricMPW logoMPWMedical Propertie…GMRE logoGMREGlobal Medical RE…
ROE (TTM)Return on equity-4.3%+0.5%
ROA (TTM)Return on assets-1.3%+0.2%
ROICReturn on invested capital+2.0%
ROCEReturn on capital employed+5.3%
Piotroski ScoreFundamental quality 0–954
Debt / EquityFinancial leverage0.03x1.18x
Net DebtTotal debt minus cash-$413M$647M
Cash & Equiv.Liquid assets$541M$7M
Total DebtShort + long-term debt$128M$654M
Interest CoverageEBIT ÷ Interest expense1.14x
MPW leads this category, winning 4 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

GMRE leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in GMRE five years ago would be worth $7,855 today (with dividends reinvested), compared to $4,381 for MPW. Over the past 12 months, MPW leads with a +18.6% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors GMRE at 1.8% vs MPW's -6.0% — a key indicator of consistent wealth creation.

MetricMPW logoMPWMedical Propertie…GMRE logoGMREGlobal Medical RE…
YTD ReturnYear-to-date+13.0%+6.9%
1-Year ReturnPast 12 months+18.6%+0.1%
3-Year ReturnCumulative with dividends-16.9%+5.6%
5-Year ReturnCumulative with dividends-56.2%-21.4%
10-Year ReturnCumulative with dividends-0.3%+308.1%
CAGR (3Y)Annualised 3-year return-6.0%+1.8%
GMRE leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

MPW leads this category, winning 2 of 2 comparable metrics.

MPW is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than GMRE's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MPW currently trades 95.4% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMPW logoMPWMedical Propertie…GMRE logoGMREGlobal Medical RE…
Beta (5Y)Sensitivity to S&P 5000.30x0.48x
52-Week HighHighest price in past year$5.92$39.93
52-Week LowLowest price in past year$3.95$29.05
% of 52W HighCurrent price vs 52-week peak+95.4%+89.5%
RSI (14)Momentum oscillator 0–10058.952.7
Avg Volume (50D)Average daily shares traded1.8M130K
MPW leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

GMRE leads this category, winning 1 of 1 comparable metric.

Wall Street rates MPW as "Hold" and GMRE as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -11.5% for MPW (target: $5). GMRE is the only dividend payer here at 63.51% yield — a key consideration for income-focused portfolios.

MetricMPW logoMPWMedical Propertie…GMRE logoGMREGlobal Medical RE…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$5.00$40.00
# AnalystsCovering analysts2822
Dividend YieldAnnual dividend ÷ price+63.5%
Dividend StreakConsecutive years of raises05
Dividend / ShareAnnual DPS$22.70
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
GMRE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

GMRE leads in 3 of 6 categories (Valuation Metrics, Total Returns). MPW leads in 2 (Profitability & Efficiency, Risk & Volatility). 1 tied.

Best OverallGlobal Medical REIT Inc. (GMRE)Leads 3 of 6 categories
Loading custom metrics...

MPW vs GMRE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MPW or GMRE a better buy right now?

For growth investors, Global Medical REIT Inc.

(GMRE) is the stronger pick with -1. 8% revenue growth year-over-year, versus -2. 4% for Medical Properties Trust, Inc. (MPW). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MPW or GMRE?

On forward P/E, Medical Properties Trust, Inc.

is actually cheaper at 49. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — MPW or GMRE?

Over the past 5 years, Global Medical REIT Inc.

(GMRE) delivered a total return of -21. 4%, compared to -56. 2% for Medical Properties Trust, Inc. (MPW). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus MPW's -0. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MPW or GMRE?

By beta (market sensitivity over 5 years), Medical Properties Trust, Inc.

(MPW) is the lower-risk stock at 0. 30β versus Global Medical REIT Inc. 's 0. 48β — meaning GMRE is approximately 58% more volatile than MPW relative to the S&P 500. On balance sheet safety, Medical Properties Trust, Inc. (MPW) carries a lower debt/equity ratio of 3% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MPW or GMRE?

By revenue growth (latest reported year), Global Medical REIT Inc.

(GMRE) is pulling ahead at -1. 8% versus -2. 4% for Medical Properties Trust, Inc. (MPW). On earnings-per-share growth, the picture is similar: Medical Properties Trust, Inc. grew EPS 91. 8% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, GMRE leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MPW or GMRE?

Global Medical REIT Inc.

(GMRE) is the more profitable company, earning 4. 8% net margin versus -20. 4% for Medical Properties Trust, Inc. — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MPW leads at 38. 1% versus 23. 6% for GMRE. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MPW or GMRE more undervalued right now?

On forward earnings alone, Medical Properties Trust, Inc.

(MPW) trades at 49. 4x forward P/E versus 595. 7x for Global Medical REIT Inc. — 546. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

08

Which pays a better dividend — MPW or GMRE?

In this comparison, GMRE (63.

5% yield) pays a dividend. MPW does not pay a meaningful dividend and should not be held primarily for income.

09

Is MPW or GMRE better for a retirement portfolio?

For long-horizon retirement investors, Global Medical REIT Inc.

(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, MPW: -0. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MPW and GMRE?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MPW is a small-cap quality compounder stock; GMRE is a small-cap income-oriented stock. GMRE pays a dividend while MPW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MPW

Quality Business

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

GMRE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 41%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MPW and GMRE on the metrics below

Revenue Growth>
%
(MPW: 14.9% · GMRE: 18.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.